- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Trends in Pharmacological Sciences, 45, 6, S. 475-477
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2024
- Ereignis
-
Veröffentlichung
- (wer)
-
Elsevier BV
- (wann)
-
2024
- Urheber
- DOI
-
10.1016/j.tips.2024.04.011
- URN
-
urn:nbn:de:bvb:384-opus4-1130960
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Noeparast, Maxim
- Timofeev, Oleg
- Pichler, Martin
- Universität Augsburg
- Elsevier BV
Entstanden
- 2024
Ähnliche Objekte (12)
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain
Best of ASCO 2022: bladder cancer
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: a multinational cross-sectional survey
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Tumor macroenvironment and metabolism
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain
Best of ASCO 2022: bladder cancer
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: a multinational cross-sectional survey
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Tumor macroenvironment and metabolism
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain
Best of ASCO 2022: bladder cancer
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: a multinational cross-sectional survey
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition